medRxiv PreprintsInternational15 October 2026
Attenuated GlycoRNA-microglial transcriptional coupling in the dorsolateral prefrontal cortex of patients with major depressive disorder: an exploratory interaction-based in-silico analysis
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Abstract Background: Glycosylated RNAs (GlycoRNAs) participate in immune recognition and intercellular communication, but their relationship with brain cell-type transcriptional signatures in major depressive disorder (MDD) remains unclear. We examined GlycoRNA-related transcriptional coupling with microglial and other cellular signatures in the dorsolateral prefrontal cortex (DLPFC). Method: Postmortem DLPFC transcriptomic data from 22 controls and 26 MDD patients (GSE102556) were analyzed. GlycoRNA-related pathway enrichment was quantified using gene set variation analysis (GSVA), whereas mi
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- To TTV or Not to TTV? A Combined Urinary Biomarker Approach in Kidney Transplant Recipients Using Torque Teno Virus, Cell-Free DNA, and BK Polyomavirus Measurements15 October 2026
- How healthcare professionals manage uncertainty around hormone replacement therapy (dis-)continuation: the TAPER qualitative Study15 October 2026
- Wide-angled proteomics in giant cell arteritis reveals complement pathway activation15 October 2026
- Calibration, Uncertainty, and Data Efficiency of Deep Learning Chest Radiograph Classifiers Under Cross-Dataset Distribution Shift: A Multi-Dataset Benchmark15 October 2026
- Knowledge, Attitudes, and Practices Regarding Antimicrobial Resistance Among Users of an Indian Digital Healthcare Platform: A Cross-sectional Online Survey15 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.